COVID-19 UPDATE: Click here for current news.
The Rx Consultant

Charts & Tables

Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site. Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.
Title Publication Dateasc
Risks of Legal Entanglement: Cautions, Cases & Counteractions - 7 Exceptions to the "No Duty to Warn" Rule 07/01/2021
Risks of Legal Entanglement: Cautions, Cases & Counteractions - Protecting Children 07/01/2021
Risks of Legal Entanglement: ISMP Community/Ambulatory Care Pharmacy High Alert Medications 07/01/2021
Risks of Legal Entanglement: ISMP Community/Ambulatory Care Pharmacy Opioid Resources 07/01/2021
Risks of Legal Entanglement: ISMP Community/Ambulatory Care Pharmacy Selected Causative Medications and Populations Predisposed to Stevens-Johnson Syndrome 07/01/2021
Pharmacist Prescribing Practical and Legal Considerations - Models for Prescriptive Authority 09/01/2020
Pharmacist Prescribing Practical and Legal Considerations - States With Independent Prescriptive Authority: Part 1 09/01/2020
Pharmacist Prescribing Practical and Legal Considerations - States With Independent Prescriptive Authority: Part 2 09/01/2020
Pharmacist Prescribing Practical and Legal Considerations - States with Pharmacist Authority to Prescribe Selected Drug Categories 09/01/2020
Pharmacist Prescribing Practical and Legal Considerations - Pharmacist Response to COVID-19: A Call to Action 09/01/2020
Pharmacist Prescribing Practical and Legal Considerations - Resources and Suggested Reading 09/01/2020
Pharmacy Law - A Focus on Opioid Prescriptions: Corresponding Responsibility Doctrine 07/01/2019
Pharmacy Law - A Focus on Opioid Prescriptions: Opioid Prescription Concerns: Red Flags 07/01/2019
Pharmacy Law - A Focus on Opioid Prescriptions: Open-Ended Patient Education 07/01/2019
Pharmacy Law - A Focus on Opioid Prescriptions: Examples of 50 and 90 Morphine Milligram Equivalents (MME) 07/01/2019
Pharmacy Law - A Focus on Opioid Prescriptions: Pharmacist Resources 07/01/2019
Pharmacy Law - A Focus on Opioid Prescriptions: Tips for Safe Opioid Use 07/01/2019
Pharmacy Law - A Focus on Opioid Prescriptions: Patient Resources for More Information 07/01/2019
Pharmacy Law Regulatory Developments Affecting Pharmacy Practice: Traditional Compounding Requirements under 503A 07/01/2017
Pharmacy Law: Regulatory Developments Affecting Pharmacy Practice Compounding Quality Act - Comparison of 503A With 503B 07/01/2017
Pharmacy Law Regulatory Developments Affecting Pharmacy Practice: Drug Supply Chain Security Act - Key Provisions 07/01/2017
Pharmacy Law Regulatory Developments Affecting Pharmacy Practice: Medications That May Be Flushed 07/01/2017
Pharmacy Law Regulatory Developments Affecting Pharmacy Practice: Resources 07/01/2017
National Standards on Culturally and Linguistically Appropriate Services (CLAS) in Health Care 09/01/2011
United States Pharmacopeia (USP) Advisory Panel Recommendations to Improve Prescription Drug Labels 09/01/2011
Legal/Regulatory Concerns: Position of Regulators 11/01/2009
Pharmacy Law Resources 11/01/2009
The Federal Controlled Substances Act 11/01/2009
Warning Signs That Prescriptions May Not Be Legitimate 11/01/2009
Pharmacy Law Implications for Practice: Compounding 11/01/2007
Pharmacy Law Implications for Practice: Drug Pedigrees 11/01/2007
Pharmacy Law Implications for Practice: Patient Access to Investigational Drugs 11/01/2007
Pharmacy Law Implications for Practice: Medicaid Reimbursement 11/01/2007
Pharmacy Law Implications for Practice: The Marketing of Unapproved Drugs 11/01/2007
Pharmacy Law Implications for Practice: Multiple Schedule II Prescriptions 11/01/2007